KNSA logo

Kiniksa Pharmaceuticals (KNSA) Cash from investing

annual CFI:

$37.67M+$67.23M(+227.46%)
December 31, 2024

Summary

  • As of today (May 29, 2025), KNSA annual cash flow from investing activities is $37.67 million, with the most recent change of +$67.23 million (+227.46%) on December 31, 2024.
  • During the last 3 years, KNSA annual CFI has fallen by -$90.96 million (-70.71%).
  • KNSA annual CFI is now -70.71% below its all-time high of $128.63 million, reached on December 31, 2021.

Performance

KNSA Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

quarterly CFI:

-$51.54M-$116.83M(-178.94%)
March 31, 2025

Summary

  • As of today (May 29, 2025), KNSA quarterly cash flow from investing activities is -$51.54 million, with the most recent change of -$116.83 million (-178.94%) on March 31, 2025.
  • Over the past year, KNSA quarterly CFI has dropped by -$77.06 million (-301.93%).
  • KNSA quarterly CFI is now -158.05% below its all-time high of $88.79 million, reached on March 31, 2020.

Performance

KNSA quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

TTM CFI:

-$39.39M-$77.06M(-204.57%)
March 31, 2025

Summary

  • As of today (May 29, 2025), KNSA TTM cash flow from investing activities is -$39.39 million, with the most recent change of -$77.06 million (-204.57%) on March 31, 2025.
  • Over the past year, KNSA TTM CFI has dropped by -$73.28 million (-216.25%).
  • KNSA TTM CFI is now -115.93% below its all-time high of $247.32 million, reached on September 30, 2021.

Performance

KNSA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

KNSA Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+227.5%-301.9%-216.3%
3 y3 years-70.7%-126.8%-164.5%
5 y5 years-23.4%-158.1%-126.8%

KNSA Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.7%+227.5%-178.9%at low-164.5%+31.3%
5 y5-year-70.7%+227.5%-158.1%+65.6%-115.9%+56.3%
alltimeall time-70.7%+115.8%-158.1%+73.5%-115.9%+85.3%

KNSA Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$51.54M(-178.9%)
-$39.39M(-204.6%)
Dec 2024
$37.67M(-227.5%)
$65.29M(-1128.6%)
$37.67M(-188.6%)
Sep 2024
-
-$6.35M(-86.4%)
-$42.52M(-12.2%)
Jun 2024
-
-$46.80M(-283.3%)
-$48.44M(-243.0%)
Mar 2024
-
$25.52M(-271.4%)
$33.89M(-214.6%)
Dec 2023
-$29.56M(+265.9%)
-$14.89M(+21.3%)
-$29.56M(-48.4%)
Sep 2023
-
-$12.28M(-134.6%)
-$57.32M(+120.4%)
Jun 2023
-
$35.53M(-193.7%)
-$26.01M(+11.7%)
Mar 2023
-
-$37.92M(-11.1%)
-$23.27M(+188.1%)
Dec 2022
-$8.08M(-106.3%)
-$42.66M(-324.1%)
-$8.08M(-47.7%)
Sep 2022
-
$19.04M(-50.2%)
-$15.46M(-215.8%)
Jun 2022
-
$38.27M(-268.4%)
$13.35M(-78.1%)
Mar 2022
-
-$22.72M(-54.6%)
$61.08M(-52.5%)
Dec 2021
$128.63M(-648.7%)
-$50.04M(-204.6%)
$128.63M(-48.0%)
Sep 2021
-
$47.85M(-44.4%)
$247.32M(+396.5%)
Jun 2021
-
$85.99M(+91.8%)
$49.81M(-173.9%)
Mar 2021
-
$44.83M(-34.7%)
-$67.40M(+187.5%)
DateAnnualQuarterlyTTM
Dec 2020
-$23.44M(-147.6%)
$68.64M(-145.9%)
-$23.44M(-74.0%)
Sep 2020
-
-$149.66M(+379.4%)
-$90.17M(-220.7%)
Jun 2020
-
-$31.22M(-135.2%)
$74.70M(-49.3%)
Mar 2020
-
$88.79M(+4534.1%)
$147.28M(+199.3%)
Dec 2019
$49.21M(-120.6%)
$1.92M(-87.4%)
$49.21M(-36.1%)
Sep 2019
-
$15.21M(-63.2%)
$76.96M(-157.8%)
Jun 2019
-
$41.36M(-545.8%)
-$133.13M(-46.4%)
Mar 2019
-
-$9.28M(-131.3%)
-$248.40M(+3.8%)
Dec 2018
-$239.20M(>+9900.0%)
$29.66M(-115.2%)
-$239.20M(-11.0%)
Sep 2018
-
-$194.87M(+163.7%)
-$268.86M(+263.2%)
Jun 2018
-
-$73.91M(>+9900.0%)
-$74.02M(>+9900.0%)
Mar 2018
-
-$75.00K(+1775.0%)
-$126.00K(+82.6%)
Dec 2017
-$69.00K(+2200.0%)
-$4000.00(-85.7%)
-$69.00K(+6.2%)
Sep 2017
-
-$28.00K(+47.4%)
-$65.00K(+75.7%)
Jun 2017
-
-$19.00K(+5.6%)
-$37.00K(+105.6%)
Mar 2017
-
-$18.00K
-$18.00K
Dec 2016
-$3000.00
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual CFI year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?

What is Kiniksa Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of KNSA is $37.67M

What is the all time high annual CFI for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual cash flow from investing activities is $128.63M

What is Kiniksa Pharmaceuticals annual CFI year-on-year change?

Over the past year, KNSA annual cash flow from investing activities has changed by +$67.23M (+227.46%)

What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of KNSA is -$51.54M

What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly cash flow from investing activities is $88.79M

What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, KNSA quarterly cash flow from investing activities has changed by -$77.06M (-301.93%)

What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of KNSA is -$39.39M

What is the all time high TTM CFI for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM cash flow from investing activities is $247.32M

What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?

Over the past year, KNSA TTM cash flow from investing activities has changed by -$73.28M (-216.25%)
On this page